Biglycan has been demonstrated to trigger the synthesis of the macrophage chemoattractants chemokine (C-C motif) ligand CCL2 and CCL5 [56]; thus, it may be possible that biglycan deficiency modulates tumor vasculature through recruitment of macrophages. Here, CCL5 is linked to neoplasm.